BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16919656)

  • 1. Quantitative structure-retention relationship studies using immobilized artificial membrane chromatography I: amended linear solvation energy relationships with the introduction of a molecular electronic factor.
    Li J; Sun J; Cui S; He Z
    J Chromatogr A; 2006 Nov; 1132(1-2):174-82. PubMed ID: 16919656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-retention relationship studies with immobilized artificial membrane chromatography II: partial least squares regression.
    Li J; Sun J; He Z
    J Chromatogr A; 2007 Jan; 1140(1-2):174-9. PubMed ID: 17161410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases.
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of retention indices of drugs based on immobilized artificial membrane chromatography using Projection Pursuit Regression and Local Lazy Regression.
    Du H; Watzl J; Wang J; Zhang X; Yao X; Hu Z
    J Sep Sci; 2008 Jul; 31(12):2325-33. PubMed ID: 18491354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilized artificial membrane chromatography: quantitative structure-retention relationships of structurally diverse drugs.
    Luco JM; Salinas AP; Torriero AA; Vázquez RN; Raba J; Marchevsky E
    J Chem Inf Comput Sci; 2003; 43(6):2129-36. PubMed ID: 14632465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2005; 25(4-5):379-86. PubMed ID: 15979535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids.
    Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S
    J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the retention behavior of organic and pharmaceutical drug molecules on an immobilized artificial membrane column with the Abraham model.
    Sprunger L; Blake-Taylor BH; Wairegi A; Acree WE; Abraham MH
    J Chromatogr A; 2007 Aug; 1160(1-2):235-45. PubMed ID: 17543312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2008 Apr; 1187(1-2):67-78. PubMed ID: 18291408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
    Grumetto L; Carpentiero C; Barbato F
    Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of immobilized artificial membrane-liquid chromatography retention of some drugs from their molecular structure descriptors and LFER parameters.
    Fatemi MH; Shamseddin H
    J Sep Sci; 2009 Oct; 32(20):3395-402. PubMed ID: 19750506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L; Russo G; Barbato F
    Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
    Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
    J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
    Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
    J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
    Stępnik KE; Malinowska I
    J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilicity parameter from high-performance liquid chromatography on an immobilized artificial membrane column and its relationships to bioactivity of the group of 2,4-dihydroxythiobenzanilides.
    Jóźwiak K; Szumiło H; Senczyna B
    Acta Pol Pharm; 2002; 59(5):341-6. PubMed ID: 12602794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of phospholipophilicity of 1-[3-(arylpiperazin-1-yl)-propyl]-pyrrolidin-2-one derivatives on immobilized artificial membrane stationary phase and its correlation with biological data.
    Kulig K; Malawska B
    Biomed Chromatogr; 2006 Nov; 20(11):1129-35. PubMed ID: 16708395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.